1-3 of 3
Kathy Hogan, PharmD
Close
Sort by
Journal Articles

Comparison Between Pegfilgrastim and Filgrastim-Based Autologous Hematopoietic Stem Cell Mobilization in the Setting of Patient Adapted (“Just in Time”) Plerixafor: Efficacy and Cost Analysis

Luciano J Costa, MD, PhD, Kathy Hogan, PharmD, Cindy Kramer, RN, BSN, OCN, Coleen Butcher, RN, BSN, Amanda Littleton, RN, BSN, Katie B Shoptaw, RN, BSN, MSN, Yubin Kang, MD., Robert K Stuart, MD
Journal: Blood
Blood (2011) 118 (21): 1921.
https://doi.org/10.1182/blood.V118.21.1921.1921
Published: 2011
Journal Articles

Extended Use of Ciprofloxacin Markedly Decreases the Incidence of Severe BK Virus-Associated Hemorrhagic Cystitis In Allogeneic HSCT Recipients

Ashley N Miller, FNP, MPH, Ashley S Glode, PharmD, Kathy Hogan, PharmD, Christine Schaub, ANP, AOCN, Robert K Stuart, MD, Luciano J Costa, MD., PhD
Journal: Blood
Blood (2010) 116 (21): 2317.
https://doi.org/10.1182/blood.V116.21.2317.2317
Published: 2010
Journal Articles

Effects of Method of Peripheral Blood Hematopoietic Stem Cell Mobilization (G-CSF, G-CSF + Plerixafor, or Cyclophosphamide + G/GM-CSF) on Engraftment and Sustained Graft Function: Comparison Across Cohorts with Similar CD34+ Cell Dose

Erin T Alexander, MD, Kathy Hogan, PharmD, Ashley N Miller, FNP, MPH, Robert K Stuart, MD, Luciano J Costa, MD;, PhD
Journal: Blood
Blood (2010) 116 (21): 2255.
https://doi.org/10.1182/blood.V116.21.2255.2255
Published: 2010